دورية أكاديمية
MO18-4 RAS status in ctDNA and efficacy of FOLFIRI plus ramucirumab in 2nd-line therapy for RAS wild-type mCRC: JACCRO CC-16AR
| العنوان: | MO18-4 RAS status in ctDNA and efficacy of FOLFIRI plus ramucirumab in 2nd-line therapy for RAS wild-type mCRC: JACCRO CC-16AR |
|---|---|
| المؤلفون: | Sunakawa, Yu, Yasui, Hisateru, Matsuura, Masato, Mine, Takashi, Yuasa, Yasuhiro, Watanabe, Takanori, Kinjo, Tatsuya, Okita, Yoshihiro, Okuyama, Hiroyuki, Yuki, Satoshi, Miyakawa, Koki, Kobara, Ayana, Ichikawa, Wataru, Fujii, Masashi, Tsuji, Akihito |
| المصدر: | Annals of Oncology ; volume 34, page S1407 ; ISSN 0923-7534 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2023 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Oncology, Hematology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.annonc.2023.09.199 |
| الإتاحة: | https://doi.org/10.1016/j.annonc.2023.09.199Test https://api.elsevier.com/content/article/PII:S0923753423010359?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0923753423010359?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.97F069BB |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.annonc.2023.09.199 |
|---|